Reciprocal regulation of platelet responses to P2Y and thromboxane receptor activation

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 3, 2008, Pages 534-543

  Barton, J F ^a   Hardy, A R ^a   Poole, A W ^a   Mundell, Stuart J ^a  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

Heterologousv desensitization; P2Y12; P2YI; TP receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM; G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE; PROTEIN KINASE C; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; THROMBOXANE A2; THROMBOXANE DERIVATIVE; THROMBOXANE RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CALCIUM; CYCLIC AMP; CYTOSOL; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PROTEIN KINASE C; RECEPTORS, PURINERGIC P2; RECEPTORS, THROMBOXANE; SEROTONIN; SIGNAL TRANSDUCTION; THROMBOXANES;

EID: 39549121456     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02866.x     Document Type: Article

References (37)

1. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol Rev 1999; 79: 1193-226.
2. Murugappan S, Shankar H, Kunapuli SP. Platelet receptors for adenine nucleotides and thromboxane A2. Semin Thromb Hemost 2004; 30: 411-8.
3. Narumiya S, Hirata N, Namba T, Hayashi Y, Ushikubi F, Sugimoto Y, Negishi M, Ichikawa A. Structure and function of prostanoid receptors. J Lipid Mediat 1993; 6: 155-61.
4. Hirata T, Ushikubi F, Kakizuka A, Okuma M, Narumiya S. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996; 97: 949-56.
5. Gachet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 2006; 47: 277-300.
6. Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, Quinton TM. ADP receptors-targets for developing antithrombotic agents. Curr Pharm Des 2003; 9: 2303-16.
7. Leon C, Vial C, Cazenave JP, Gachet C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene 1996; 171: 295-7.
8. Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP. Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Comm 1996; 218: 783-8.
9. Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273: 2030-4.
10. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Letts 1998; 422: 291-5.
11. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nature Med 1999; 5: 1199-202.
12. Macfarlane DE, Srivastava PC, Mills DC. 2-Methylthioadenosine [beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest 1983; 71: 420-8.
13. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishan V, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409: 202-7.
14. Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107: 1591-8.
15. Savi P, Labouret C, Delesque N, Guette F, Lupker J, Herbert JM. P2y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 2001; 283: 379-83.
16. Defreyn G, Bernat A, Delebassee D, Maffrand JP. Pharmacology of ticlopidine: A review. Semin Thromb Hemost 1989; 15: 159-66.
17. Moussa IOM, Rubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantations. Circulation 1999; 99: 2364-6.
18. Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 2005; 105: 3552-60.
19. Mundell SJ, Jones ML, Collins J, Hardy AR, Beaucourt SM, Conley PB, Poole AW. Specific protein kinase C isoforms regulate platelet purinergic receptor function. Mol Pharmacol 2006; 70: 1132-42.
20. Poole AW, Heath MF, Evans RJ. ADP induces desensitisation of equine platelet aggregation responses: Studies using ADP beta S, a stable analogue of ADP. Res Vet Sci 1993; 54: 235-43.
21. Baurand A, Eckly A, Bari N, Leon C, Hechler B, Cazenave JP, et al. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 2000; 84: 484-91.
22. Baurand A, Eckly A, Hechler B, Kauffenstein G, Galzi JL, Cazenave JP, et al. Differential regulation and relocalization of the platelet P2Y receptors after activation: A way to avoid loss of hemostatic properties? Mol Pharmacol 2005; 67: 721-33.
23. Murray R, FitzGerald GA. Regulation of thromboxane receptor activation in human platelets. Proc Natl Acad Sci U S A 1989; 86: 124-8.
24. Murray R, Shipp E, FitzGerald GA. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets. J Biol Chem 1990; 265: 21670-5.
25. Okwu AK, Ullian ME, Halushka PV. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther 1992; 262: 238-45.
26. Cordeaux Y, Hill SJ. Mechanisms of cross-talk between G-protein-coupled receptors. Neurosignals 2002; 11: 45-57.
27. Poole AW, Watson SP, Heath MF, Evans RJ. Regulation of cytosolic calcium by collagen in single human platelets. Br J Pharmacol 1995; 115: 101-6.
28. Kelley-Hickie LP, Kinsella BT. EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor. Br J Pharmacol 2004; 142: 203-21.
29. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993; 268: 9194-7.
30. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, et al. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 1994; 199: 93-8.
31. Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic 2006; 7: 1420-31.
32. Tulapurkar ME, Zundorf G, Reiser G. Internalization and desensitization of a green fluorescent protein-tagged P2Y nucleotide receptor are differently controlled by inhibition of calmodulin-dependent protein kinase II. J Neurochem 2006; 96: 624-34.
33. Okwu AK, Mais DE, Halushka PV. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Biochim Biophys Acta 1994; 1221: 83-8.
34. Hill MM, Andjelkovic M, Brazil DP, Ferrari S, Fabbro D, Hemmings BA. Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J Biol Chem 2001; 276: 25643-6.
35. Parent JL, Labrecque P, Orsini MJ, Benovic JL. Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced cooh terminus in agonist-promoted receptor internalization. J Biol Chem 1999; 274: 8941-8.
36. Walsh MT, Foley JF, Kinsella BT. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization. J Biol Chem 2000; 275: 20412-23.
37. Reid HM, Kinsella BT. The α, but not the β, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization: Independent modulation of TPα signalling by nitric oxide and prostacyclin. J Biol Chem 2003; 278: 51190-202.